Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

This study has been terminated.
(Sponsor no longer funding study.)
Sponsor:
Collaborator:
Genentech
Information provided by (Responsible Party):
Craig Kessler, Georgetown University
ClinicalTrials.gov Identifier:
NCT00306670
First received: March 23, 2006
Last updated: January 9, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)